
Suzanne Marie Noakes
Examiner (ID: 17824)
| Most Active Art Unit | 1656 |
| Art Unit(s) | 1656, 1653 |
| Total Applications | 1691 |
| Issued Applications | 1090 |
| Pending Applications | 193 |
| Abandoned Applications | 452 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17075130
[patent_doc_number] => 11111516
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-07
[patent_title] => malR-knockout
[patent_app_type] => utility
[patent_app_number] => 16/970397
[patent_app_country] => US
[patent_app_date] => 2019-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3338
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 358
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16970397
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/970397 | malR-knockout | Aug 4, 2019 | Issued |
Array
(
[id] => 18036203
[patent_doc_number] => 20220380418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => NOVEL INSECTICIDAL TOXIN RECEPTORS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/266318
[patent_app_country] => US
[patent_app_date] => 2019-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15152
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17266318
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/266318 | Insecticidal toxin receptors and methods of use | Aug 1, 2019 | Issued |
Array
(
[id] => 16642372
[patent_doc_number] => 10920213
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-16
[patent_title] => Heat-resistant carbonic anhydrase mutants and composition for capturing carbon dioxide containing the same
[patent_app_type] => utility
[patent_app_number] => 16/525935
[patent_app_country] => US
[patent_app_date] => 2019-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 4532
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16525935
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/525935 | Heat-resistant carbonic anhydrase mutants and composition for capturing carbon dioxide containing the same | Jul 29, 2019 | Issued |
Array
(
[id] => 17287219
[patent_doc_number] => 11203760
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-21
[patent_title] => Gene therapy DNA vector GDTT1.8NAS12 and the method for obtaining thereof
[patent_app_type] => utility
[patent_app_number] => 17/273035
[patent_app_country] => US
[patent_app_date] => 2019-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 9484
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17273035
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/273035 | Gene therapy DNA vector GDTT1.8NAS12 and the method for obtaining thereof | Jul 25, 2019 | Issued |
Array
(
[id] => 16091133
[patent_doc_number] => 20200199553
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => SITE-SPECIFIC ENZYMES AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/518126
[patent_app_country] => US
[patent_app_date] => 2019-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34172
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16518126
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/518126 | Site-specific enzymes and methods of use | Jul 21, 2019 | Issued |
Array
(
[id] => 16832358
[patent_doc_number] => 11008599
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-18
[patent_title] => Variant phosphoribosylpyrophosphate amidotransferase and method of preparing purine nucleotide using the same
[patent_app_type] => utility
[patent_app_number] => 16/493661
[patent_app_country] => US
[patent_app_date] => 2019-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9734
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16493661
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/493661 | Variant phosphoribosylpyrophosphate amidotransferase and method of preparing purine nucleotide using the same | Jul 18, 2019 | Issued |
Array
(
[id] => 18685184
[patent_doc_number] => 11780902
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-10-10
[patent_title] => Receptor/histidine kinase fusion constructs and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/517107
[patent_app_country] => US
[patent_app_date] => 2019-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 27
[patent_no_of_words] => 17508
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16517107
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/517107 | Receptor/histidine kinase fusion constructs and uses thereof | Jul 18, 2019 | Issued |
Array
(
[id] => 15619325
[patent_doc_number] => 20200080067
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-12
[patent_title] => CRISPR-CAS SYSTEMS, CRYSTAL STRUCTURE AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/517534
[patent_app_country] => US
[patent_app_date] => 2019-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40703
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16517534
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/517534 | CRISPR-CAS SYSTEMS, CRYSTAL STRUCTURE AND USES THEREOF | Jul 18, 2019 | Abandoned |
Array
(
[id] => 15178197
[patent_doc_number] => 20190359690
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-28
[patent_title] => THERAPEUTIC VARIANT ALPHA-2-MACROGLOBULIN COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/514591
[patent_app_country] => US
[patent_app_date] => 2019-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33105
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16514591
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/514591 | Therapeutic variant alpha-2-macroglobulin compositions | Jul 16, 2019 | Issued |
Array
(
[id] => 15178197
[patent_doc_number] => 20190359690
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-28
[patent_title] => THERAPEUTIC VARIANT ALPHA-2-MACROGLOBULIN COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/514591
[patent_app_country] => US
[patent_app_date] => 2019-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33105
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16514591
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/514591 | Therapeutic variant alpha-2-macroglobulin compositions | Jul 16, 2019 | Issued |
Array
(
[id] => 18636394
[patent_doc_number] => 11760981
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-19
[patent_title] => Engineered glycosyltransferases and steviol glycoside glucosylation methods
[patent_app_type] => utility
[patent_app_number] => 16/514578
[patent_app_country] => US
[patent_app_date] => 2019-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 58879
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16514578
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/514578 | Engineered glycosyltransferases and steviol glycoside glucosylation methods | Jul 16, 2019 | Issued |
Array
(
[id] => 19311829
[patent_doc_number] => 12037632
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-16
[patent_title] => Recombinant expression vector applicable to rapid screening for recombinant strain and application
[patent_app_type] => utility
[patent_app_number] => 17/263562
[patent_app_country] => US
[patent_app_date] => 2019-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 10
[patent_no_of_words] => 4400
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17263562
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/263562 | Recombinant expression vector applicable to rapid screening for recombinant strain and application | Jul 12, 2019 | Issued |
Array
(
[id] => 15178117
[patent_doc_number] => 20190359650
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-28
[patent_title] => METHODS FOR EXTRACTING KERATIN PROTEINS
[patent_app_type] => utility
[patent_app_number] => 16/507181
[patent_app_country] => US
[patent_app_date] => 2019-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6190
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16507181
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/507181 | Methods for extracting keratin proteins | Jul 9, 2019 | Issued |
Array
(
[id] => 15041347
[patent_doc_number] => 20190331678
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-31
[patent_title] => GENETICALLY ENCODED BIOSENSORS
[patent_app_type] => utility
[patent_app_number] => 16/460112
[patent_app_country] => US
[patent_app_date] => 2019-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20180
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16460112
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/460112 | GENETICALLY ENCODED BIOSENSORS | Jul 1, 2019 | Abandoned |
Array
(
[id] => 15264835
[patent_doc_number] => 20190381151
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-19
[patent_title] => Chimeric Polypeptides and Their Use in Bacterial Decolonization
[patent_app_type] => utility
[patent_app_number] => 16/454196
[patent_app_country] => US
[patent_app_date] => 2019-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16487
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16454196
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/454196 | Chimeric polypeptides and their use in bacterial decolonization | Jun 26, 2019 | Issued |
Array
(
[id] => 17067567
[patent_doc_number] => 20210269782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => RNA-GUIDED EFFECTOR PROTEINS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/057531
[patent_app_country] => US
[patent_app_date] => 2019-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55720
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -76
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17057531
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/057531 | RNA-GUIDED EFFECTOR PROTEINS AND METHODS OF USE THEREOF | Jun 24, 2019 | Abandoned |
Array
(
[id] => 16375060
[patent_doc_number] => 20200323902
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-15
[patent_title] => ENHANCED hAT FAMILY TRANSPOSON-MEDIATED GENE TRANSFER AND ASSOCIATED COMPOSITIONS, SYSTEMS, AND METHODS
[patent_app_type] => utility
[patent_app_number] => 16/448263
[patent_app_country] => US
[patent_app_date] => 2019-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24814
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16448263
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/448263 | Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods | Jun 20, 2019 | Issued |
Array
(
[id] => 15294191
[patent_doc_number] => 20190390231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-26
[patent_title] => METHOD FOR THE MICROBIAL PRODUCTION OF 8-METHYL NONANOIC ACID
[patent_app_type] => utility
[patent_app_number] => 16/444305
[patent_app_country] => US
[patent_app_date] => 2019-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11086
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16444305
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/444305 | Method for the microbial production of 8-methyl nonanoic acid | Jun 17, 2019 | Issued |
Array
(
[id] => 15239671
[patent_doc_number] => 20190374621
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-12
[patent_title] => Combination treatment for atopic dermatitis
[patent_app_type] => utility
[patent_app_number] => 16/439734
[patent_app_country] => US
[patent_app_date] => 2019-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19221
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16439734
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/439734 | Combination treatment for atopic dermatitis | Jun 12, 2019 | Abandoned |
Array
(
[id] => 14896933
[patent_doc_number] => 20190292232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-26
[patent_title] => Gluten-Derived Flame Retardant Materials
[patent_app_type] => utility
[patent_app_number] => 16/437102
[patent_app_country] => US
[patent_app_date] => 2019-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5177
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16437102
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/437102 | Gluten-Derived Flame Retardant Materials | Jun 10, 2019 | Abandoned |